These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4371948)

  • 1. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
    Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
    Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases.
    Tan C; Etcubanas E; Wollner N; Rosen G; Gilladoga A; Showel J; Murphy ML; Krakoff IH
    Cancer; 1973 Jul; 32(1):9-17. PubMed ID: 4352019
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxorubicin in treatment of malignant solid tumors in children.
    Pratt CB; Shanks EC
    Am J Dis Child; 1974 Apr; 127(4):534-6. PubMed ID: 4362485
    [No Abstract]   [Full Text] [Related]  

  • 4. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.
    Tan C; Tasaka H; Yu KP; Murphy ML; Karnofsky DA
    Cancer; 1967 Mar; 20(3):333-53. PubMed ID: 4290058
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Ewing's sarcoma with adriamycin (NSC-123127).
    Oldham RK; Pomeroy TC
    Cancer Chemother Rep; 1972 Oct; 56(5):635-9. PubMed ID: 4569057
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a high dose cyclophosphamide regimen in childhood tumors.
    Finklestein JZ; Hittle RE; Hammond GD
    Cancer; 1969 May; 23(5):1239-42. PubMed ID: 4305107
    [No Abstract]   [Full Text] [Related]  

  • 7. On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
    Lenaz L; Di Marco A
    Cancer Chemother Rep; 1972 Aug; 56(4):431-2. PubMed ID: 5081585
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.
    Finklestein JZ; Albo V; Ertel I; Hammond D
    Cancer Chemother Rep; 1975; 59(2 Pt 1):351-7. PubMed ID: 167936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)].
    Bonadonna G; Beretta G; Tancini G; De Palo GM; Gasparini M; Doci R
    Tumori; 1974; 60(5):373-91. PubMed ID: 4617354
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in the pharmacology of cancer chemotherapy.
    Smith SD
    Pediatr Clin North Am; 1981 Feb; 28(1):145-60. PubMed ID: 6259577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adriamycin in the therapy of child leukemias and tumors].
    Maas B; Ruhrmann G; Wilmanns W
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):390-2. PubMed ID: 4356422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Planning of chemotherapy in cancer of children].
    Ise T
    Nihon Rinsho; 1975 May; 33(5):1856-61. PubMed ID: 50467
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
    Komp DM; Land VJ; Nitschke R; Cangir A; Dyment P
    Cancer Chemother Rep; 1975; 59(2 Pt 1):371-6. PubMed ID: 1097094
    [No Abstract]   [Full Text] [Related]  

  • 14. Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
    Massimo L; Fossati-Guglielmoni A; Fortuna E
    Helv Paediatr Acta; 1968 Aug; 23(4):315-33. PubMed ID: 4300437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of malignant tumors in children].
    Tasaka H
    Iryo; 1970 Oct; 24(10):773-82. PubMed ID: 4320171
    [No Abstract]   [Full Text] [Related]  

  • 16. [The chemotherapy of solid tumors in childhood].
    Widmer U; Morbidelli R; Naddeo-Bolgiani MP
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1967; 60(11):624-40. PubMed ID: 4304184
    [No Abstract]   [Full Text] [Related]  

  • 17. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gasparini M; Bellani FF; Musumeci R; Bonadonna G
    Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
    [No Abstract]   [Full Text] [Related]  

  • 18. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
    Davis HL; Davis TE
    Cancer Treat Rep; 1979 May; 63(5):809-15. PubMed ID: 378369
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease.
    Wang JJ; Cortes E; Sinks LF; Holland JF
    Cancer; 1971 Oct; 28(4):837-43. PubMed ID: 4329505
    [No Abstract]   [Full Text] [Related]  

  • 20. Daunorubicin (NSC-83142) in advanced childhood leukemia.
    Jaffe N; Traggis DG; Das L
    Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.